Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential,Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01083017
What this trial is testing

Resistant Arterial Hypertension Cohort Study

Who this might be right for
HypertensionEssential HypertensionResistant Hypertension
University Hospital, Geneva 74
Large-scale testing (Phase 3)Study completedNCT02620163
What this trial is testing

Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

Who this might be right for
Hypertension
Yuhan Corporation 381
Not applicableUnknownNCT06321159
What this trial is testing

Investigation of the Effect of Mobile Software Use in Blood Pressure Management of Hypertensive Individuals on Quality of Life and Disease Self-Efficacy

Who this might be right for
Hypertension, Essential Hypertension
Inonu University 614
Not applicableStudy completedNCT01392534
What this trial is testing

Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting

Who this might be right for
Primary Hypertension
Bayer 1,586
Not applicableLooking for participantsNCT04755764
What this trial is testing

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Who this might be right for
Systolic HypertensionPregnancy RelatedDiastolic Hypertension+2 more
Marshall University 60
Post-approval studies (Phase 4)UnknownNCT05165251
What this trial is testing

Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

Who this might be right for
Isolated Systolic Hypertension
Shanghai Jiao Tong University School of Medicine 480
Testing effectiveness (Phase 2)Study completedNCT00950066
What this trial is testing

Irbesartan and Amlodipine Combination in Controlling Blood Pressure

Who this might be right for
Hypertension
Sanofi 270
Large-scale testing (Phase 3)Study completedNCT00996281
What this trial is testing

Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

Who this might be right for
Essential Hypertension
Takeda 837
Post-approval studies (Phase 4)Study completedNCT00700271
What this trial is testing

Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day

Who this might be right for
Hypertension
Novartis Pharmaceuticals 478
Not applicableUnknownNCT03708601
What this trial is testing

Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)

Who this might be right for
Essential Hypertension
Beijing Institute of Heart, Lung and Blood Vessel Diseases 3,000
Not applicableLooking for participantsNCT07728630
What this trial is testing

Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Adults With Newly Diagnosed Hypertension

Who this might be right for
HypertensionEndothelial Function
Josip Juraj Strossmayer University of Osijek 80
Post-approval studies (Phase 4)Study completedNCT01828359
What this trial is testing

The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

Who this might be right for
Hypertension
Hanmi Pharmaceutical Company Limited 199
Testing effectiveness (Phase 2)Study completedNCT06212648
What this trial is testing

Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension

Who this might be right for
HypertensionEssential Hypertension
Shin Poong Pharmaceutical Co. Ltd. 253
Large-scale testing (Phase 3)Study completedNCT02368652
What this trial is testing

Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Who this might be right for
Essential Hypertension
HK inno.N Corporation 181
Testing effectiveness (Phase 2)UnknownNCT05033535
What this trial is testing

S086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shenzhen People's Hospital 10
Post-approval studies (Phase 4)Study completedNCT00496834
What this trial is testing

LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)

Who this might be right for
Hypertension
Organon and Co 201
Not applicableStudy completedNCT04495231
What this trial is testing

Sympathetic Activity and Cardiometabolic Complications

Who this might be right for
Catecholamine; OverproductionCatecholamine; SecretionMetabolic Syndrome+4 more
University of Turin, Italy 1,380
Large-scale testing (Phase 3)Not Yet RecruitingNCT06771245
What this trial is testing

A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

Who this might be right for
Mild-to-moderate Essential Hypertension
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606
Large-scale testing (Phase 3)Study completedNCT00797862
What this trial is testing

Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension

Who this might be right for
Hypertension
Novartis 1,254
Not applicableStudy completedNCT00638911
What this trial is testing

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 33,247
Next Page